Author Question: A scale in which respondents who agree with a statement also agree with milder versions of ... (Read 215 times)

wenmo

  • Hero Member
  • *****
  • Posts: 540
A scale in which respondents who agree with a statement also agree with milder versions of statements on the same continuum is a
 
  a) Guttman scale.
   b) Likert scale.
   c) Expert ranking scale.
   d) Thurstone scale.

Question 2

One key aspect of positive psychology is focusing on
 
  a) matters like contentment, hope, and happiness.
   b) ways to improve the lives of those with psychiatric illness.
   c) primarily people with high levels of achievement.
   d) basic emotions and how different people express them.



nyrave

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

a

Answer to Question 2

a



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Stevens-Johnson syndrome and Toxic Epidermal Necrolysis syndrome are life-threatening reactions that can result in death. Complications include permanent blindness, dry-eye syndrome, lung damage, photophobia, asthma, chronic obstructive pulmonary disease, permanent loss of nail beds, scarring of mucous membranes, arthritis, and chronic fatigue syndrome. Many patients' pores scar shut, causing them to retain heat.

Did you know?

No drugs are available to relieve parathyroid disease. Parathyroid disease is caused by a parathyroid tumor, and it needs to be removed by surgery.

Did you know?

You should not take more than 1,000 mg of vitamin E per day. Doses above this amount increase the risk of bleeding problems that can lead to a stroke.

Did you know?

Hippocrates noted that blood separates into four differently colored liquids when removed from the body and examined: a pure red liquid mixed with white liquid material with a yellow-colored froth at the top and a black substance that settles underneath; he named these the four humors (for blood, phlegm, yellow bile, and black bile).

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library